A molecule developed in the laboratories of Nerviano Medical Sciences is report was included "The ones to watch" of Thomson Reuters.
Read the report in PDF format
Another promising molecule developed in Nerviano (NMS-116354) began Phase 1 clinical trials on humans in Galway in Ireland.
Read Original irishtimes.com
0 comments:
Post a Comment